Posts Tagged ‘CROI’


March 8th, 2011

Really Rapid Review of CROI 2011 — and No CROI 2012 Dates

With CROI 2011 now officially over, I offer below the following Really Rapid Review™ for ID/HIV Specialists with limited time — or for those who said they went to the conference but spent the entire week shopping in the Prudential Mall and eating at Legal Seafood: Lots on PrEP.  Bottom line — it works if you take […]

February 27th, 2011

CROI 2011 Starts Today

With a fresh 4 inches of snow on the ground in Boston, the 18th Conference on Retroviruses and Opportunistic Infections (CROI) starts today. Pocket program is available here (PDF format).  Based on a (very) quick perusal, we can expect the following: Progress (lots of it) in prevention, with more from CAPRISA and iPrEx and the whole “treatment […]

May 27th, 2010

HIV Treatment is Prevention!

The Lancet has just published a large prospective study demonstrating the protective effect of HIV treatment on the risk of viral transmission: 3381 couples were eligible for analysis … Only one of 103 genetically-linked HIV-1 transmissions was from an infected participant who had started ART, corresponding to transmission rates of 0·37 (95% CI 0·09—2·04) per 100 person-years […]

February 28th, 2010

CROI 2010 Recap: No Obvious Blockbusters, But …

Ok, I’ll admit it — I didn’t see any studies presented at CROI this year that will immediately transform HIV care on a day-to-day basis.  Nothing that will alter practice right now. Nothing like last year’s NA-ACCORD, or 2008’s surprising DAD study, or 2007’s raltegravir studies, to name a few recent examples. (All subsequently published, of course — links are to […]

February 14th, 2010

Retrovirus Conference (CROI) 2010 Preview

Just as pitchers and catchers report to Spring Training this week, many HIV specialists are gearing up for the 17th Conference on Retroviruses and Opportunistic Infections (CROI), which starts this Tuesday in San Francisco. (I don’t suppose many people see the link between those two events.  Oh well.) And since the “pocket program” to the Conference has […]

April 6th, 2009

Delayed Opening Day Videos, and More

Some random HIV/ID issues while awaiting a delayed opening day here in cold, rainy Boston: If you enjoy video highlights, check out these of HIV making its way from T cell to T cell.  If you’re short on time, #’s 9-12 are particularly amazing.  Still, I don’t imagine that this video will make it to Youtube anytime […]

February 13th, 2009

CROI 2009: Greatest Hits

Fresh back from lovely Montreal, where the temperature (I’m glad to report) climbed into the balmy 40’s … Here’s a rapid-fire listing of the Greatest Hits.  As I’m sure to be leaving something off this list, happy to accept other suggestions: Interleukin-2 does not work.  The ESPRIT and SILCAAT studies are over. Yes, the CD4’s increase, but […]

February 11th, 2009

CROI 2010 Dates and Location Announced

February 16-20, 2010, San Francisco — at least according to John Mellors during his opening remarks here in Montreal. Is it really one day longer?  [Update — no, it’s Feb 17-20.] Really during the week of Presidents’ Day?  (School vacation week in New England … but I realize you can’t make everyone happy with schedules.) In other […]

January 17th, 2009

Salmonella, CDC, and How to Prevent a Cold

Today’s ID/HIV Link-o-Rama is being brought to you from the frozen tundra of Boston, MA: This past summer’s salmonella outbreak that sickened more than 1000 people was linked to raw jalapeno and serrano peppers.  In the current one, the suspected culprit is contaminated peanut butter.  Aside from the fact that raw hot peppers and peanut butter in […]

November 22nd, 2008

“Salvage” Rx for HIV: Macro Good News, Micro Bad News

I’ve written before how the number of treatment experienced patients who have no options for successful therapy has dwindled to a tiny — but unfortunate — few.  Darunavir, maraviroc, raltegravir, and etravirine (in order of FDA approval) are that good. Two presentations at recent scientific meetings confirmed the staggering efficacy of these newer drugs. Notably, both […]

HIV Information: Author Paul Sax, M.D.

Paul E. Sax, MD

Contributing Editor

NEJM Journal Watch
Infectious Diseases

Biography | Disclosures | Summaries

Learn more about HIV and ID Observations.